Femasys (FEMY) Total Current Liabilities (2020 - 2026)
Femasys' (FEMY) quarterly Total Current Liabilities came in at $3.2 million in Q1 2026, down 67.94% YoY from $9.8 million in Q1 2025, and down 13.23% on a QoQ basis from $3.6 million in Q4 2025.
Femasys (FEMY) Total Current Liabilities (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Total Current Liabilities data on file, last reported at $3.2 million in Q1 2026.
- Quarterly Total Current Liabilities fell 67.94% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 67.94% YoY) and the FY2025 annual result came in at $3.6 million, down 57.63% from the prior year.
- Total Current Liabilities slipped to $3.2 million in Q1 2026, from $3.6 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $11.0 million in Q2 2025 to a low of $1.4 million in Q2 2023.
- A 5-year average of $4.1 million and a median of $2.5 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2025 — Total Current Liabilities surged 344.95% — and 2026, when it plunged 67.94%.
- Tracing FEMY's Total Current Liabilities over 5 years: stood at $1.5 million in 2022, then jumped by 99.9% to $3.1 million in 2023, then soared by 181.03% to $8.6 million in 2024, then slumped by 57.63% to $3.6 million in 2025, then declined by 13.23% to $3.2 million in 2026.
- The last three Total Current Liabilities figures came in at $3.2 million (Q1 2026), $3.6 million (Q4 2025), and $10.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Femasys | 8.98 Mn | 7.54 Mn | 189,391.00 | 3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.16 Mn |
| Dec 31, 2025 | 3.64 Mn |
| Sep 30, 2025 | 10.54 Mn |
| Jun 30, 2025 | 10.96 Mn |
| Mar 31, 2025 | 9.84 Mn |
| Dec 31, 2024 | 8.58 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 3.05 Mn |
| Sep 30, 2023 | 2.19 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.53 Mn |
| Sep 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 1.86 Mn |
| Mar 31, 2022 | 1.63 Mn |
| Dec 31, 2021 | 1.69 Mn |
| Sep 30, 2021 | 1.82 Mn |
| Jun 30, 2021 | 2.32 Mn |